Carcinogenesis Advance Access originally published online on May 13, 2004
Carcinogenesis 2004 25(10):1795-1803; doi:10.1093/carcin/bgh187
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carcinogenesis vol.25 no.10 © Oxford University Press 2004; all rights reserved.
ARTICLE |
DNA mismatch repair pathway defects in the pathogenesis and evolution of myeloma
Northern Institute for Cancer Research, University of Newcastle upon Tyne, UK, 1 Department of Haematology, Leeds General Infirmary, Leeds, UK and 2 Department of Haematology, Royal Victoria Infirmary, Newcastle upon Tyne, UK
3 To whom correspondence should be addressed Email: ms.velangi{at}btinternet.com
Genetic instability is a prominent feature in multiple myeloma and progression of this disease from monoclonal gammopathy of uncertain significance (MGUS) and smouldering myeloma (SMM) is associated with increasing molecular and chromosomal abnormalities. The DNA mismatch repair (MMR) pathway is a post-replicational DNA repair system that maintains genetic stability by repairing mismatched bases and insertion/deletion loops mistakenly incorporated during DNA replication. Deficiencies in proteins pivotal to this pathway result in a higher mutation rate, particularly at regions of microsatellite DNA. We have investigated the proficiency of the MMR pathway in clinical samples and myeloma cell lines. Microsatellite analysis showed instability at one or more of nine loci examined in 15 from 92 patients: 7.7% of MGUS/SMM, 20.7% of MM/plasma cell leukaemia (PCL) and 12.5% of relapsed MM/PCL. An in vitro heteroduplex G/T repair assay found reduced repair in two cell lines, JIM1 and JIM3, and in two of four PCL cases and was associated with aberrant expression of at least one mismatch repair protein. Thus we show that MMR defects are found in plasma cell dyscrasias and the increased frequency during more active stages of the disease suggests a contributory role in disease progression.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. J. Hayden, P. Tewari, D. W. Morris, A. Staines, D. Crowley, A. Nieters, N. Becker, S. de Sanjose, L. Foretova, M. Maynadie, et al. Variation in DNA repair genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma Hum. Mol. Genet., December 15, 2007; 16(24): 3117 - 3127. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Matheson, L. A. Hogarth, M. C. Case, J. A.E. Irving, and A. G. Hall DHFR and MSH3 co-amplification in childhood acute lymphoblastic leukaemia, in vitro and in vivo Carcinogenesis, June 1, 2007; 28(6): 1341 - 1346. [Abstract] [Full Text] [PDF] |
||||

